Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00LMY
|
||||
Former ID |
DIB001231
|
||||
Drug Name |
RO-5212651
|
||||
Synonyms |
GPR119 agonists (type 2 diabetes); RO-5212651; RO-5312776; RO-5328185; RO-5429374; RO-5447603; RO-5447605; RO-5461212; GPR119 agonists (type 2 diabetes), Roche
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543393] | ||
Company |
Roche Holding AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(c1nc(c(Oc2c3ccn([C@@H]4[C@@H](CN(CC4)C(=O)OC(C)<br />(C)C)C)c3ncn2)cc1)C)C
|
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [543393] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.